| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MRPL1 |
| Uniprot No | Q9BYD6 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 51-325aa |
| 氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSKKTKKGA KEKTPDEKKD EIEKIKAYPY MEGEPEDDVY LKRLYPRQIY EVEKAVHLLK KFQILDFTSP KQSVYLDLTL DMALGKKKNV EPFTSVLSLP YPFASEINKV AVFTENASEV KIAEENGAAF AGGTSLIQKI WDDEIVADFY VAVPEIMPEL NRLRKKLNKK YPKLSRNSIG RDIPKMLELF KNGHEIKVDE ERENFLQTKI ATLDMSSDQI AANLQAVINE VCRHRPLNLG PFVVRAFLRS STSEGLLLKI DPLLPKEVKN EESEKEDA |
| 预测分子量 | 34 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于MRPL1重组蛋白的参考文献示例(部分文献为假设性示例，实际应用中建议进一步核实)：
1. **文献名称**：*Structural insights into MRPL1 function in mitochondrial ribosome assembly*
**作者**：Zhang Y, et al. (2020)
**摘要**：本研究通过重组表达人源MRPL1蛋白，结合冷冻电镜技术解析其在线粒体核糖体大亚基组装中的构象变化，揭示了MRPL1与16S rRNA的相互作用位点及对翻译活性的调控机制。
2. **文献名称**：*MRPL1 deficiency disrupts mitochondrial protein synthesis and exacerbates oxidative stress in cancer cells*
**作者**：Lee S, et al. (2021)
**摘要**：利用重组MRPL1蛋白进行体外功能回补实验，发现MRPL1缺失导致线粒体编码的氧化磷酸化复合物亚基合成受阻，进而引发癌细胞线粒体膜电位崩溃和凋亡敏感性增加。
3. **文献名称**：*High-yield expression and purification of recombinant MRPL1 for biochemical characterization*
**作者**：Garcia-Ruiz I, et al. (2019)
**摘要**：报道了一种在大肠杆菌中高效表达可溶性MRPL1重组蛋白的方法，并通过亲和层析和凝胶过滤纯化获得高纯度蛋白，为后续酶学及相互作用研究提供工具。
4. **文献名称**：*MRPL1 mutations impair mitochondrial translation and cause neurodegenerative disorders*
**作者**：Wang X, et al. (2022)
**摘要**：通过构建携带患者来源MRPL1突变体的重组蛋白模型，发现突变导致其与线粒体RNA聚合酶的结合能力下降，从而破坏线粒体基因组编码蛋白的合成，与早发性脑病相关。
**注意**：以上文献标题及内容为示例性质，实际引用时需通过学术数据库(如PubMed、Web of Science)核实具体信息，并优先选择同行评议的高影响力期刊论文。
**Background of MRPL1 Recombinant Protein**
MRPL1 (Mitochondrial Ribosomal Protein L1) is a component of the mitochondrial ribosome, specifically the large (39S) subunit, which plays a critical role in mitochondrial protein synthesis. Mitochondria, the energy-producing organelles, rely on their own translational machinery to synthesize essential subunits of the oxidative phosphorylation (OXPHOS) complexes. These complexes are vital for ATP production, making mitochondrial ribosomes indispensable for cellular energy homeostasis. MRPL1. encoded by nuclear DNA, is imported into mitochondria and assembled into the 39S subunit, contributing to ribosome stability and translational fidelity.
The production of recombinant MRPL1 protein involves cloning the MRPL1 gene into expression vectors, followed by overexpression in prokaryotic (e.g., *E. coli*) or eukaryotic systems. Recombinant MRPL1 retains its structural and functional properties, enabling studies on mitochondrial ribosome assembly, protein-mitochondrial RNA interactions, and the molecular basis of mitochondrial translation defects. Dysregulation of MRPL1 has been linked to mitochondrial disorders, neurodegenerative diseases, and cancer, highlighting its biomedical relevance.
Recombinant MRPL1 is widely used as a tool to investigate mitochondrial dysfunction mechanisms, screen for therapeutic agents targeting OXPHOS deficiencies, or validate genetic variants in clinical diagnostics. Its application also extends to structural biology, aiding in cryo-EM studies to resolve mitochondrial ribosome architecture. By providing a purified, functional form of MRPL1. researchers can dissect its role in health and disease, offering insights into mitochondrial biology and potential therapeutic strategies.
(Word count: 240)
×
